Funding for this research was provided by:
Versus Arthritis (21130, 20816)
Office of the Chief Scientist, Ministry of Health (ETM/304)
Received: 22 February 2021
Accepted: 3 September 2021
First Online: 4 October 2021
: DRG has received speaker fees and travel grants from MSD, Shire, Abbvie, Takeda, Vifor Pharma, Janssen and Allergan. PBW is currently an employee of Janssen. JSN is currently an employee of GSK. SWFM has received project grant funding from Boehringer Ingelheim, and has received fees from Janssen, Abbvie, and Pfizer. The other authors have no competing interests.